Mood Disorders and Inflammatory Markers: Pathophysiology and Implications for Treatment

Keyphrases

• Neurokinin B 100%
• NF-B 100%
• Substance P 100%
• Pathophysiology 100%
• Mood Disorders 100%
• Inflammatory Markers 100%
• Implications for Treatment 100%
• Vortioxetine 100%
• Inflammation 50%
• Antidepressants 50%
• Monocytes 50%
• Human Monocytes 50%
• Interleukin-6 50%
• Response to Treatment 50%
• Cytokine Production 50%
• Interleukin-4 (IL-4) 50%
• Major Depressive Disorder 50%
• Psychiatric Disorders 50%
• Brain Regions 50%
• Gene Expression 50%
• C-reactive Protein 50%
• Oxyradicals 50%
• Serum Levels 50%
• Interleukin-1β 50%
• Anti-inflammatory Effect 50%
• Bipolar Disorder 50%
• Disease-specific 50%
• Tumor Necrosis Factor-α 50%
• Innate Immune Response 50%
• Inflammatory Cytokines 50%
• Healthy Donors 50%
• Disability 50%
• M2 Macrophages 50%
• Interleukin 50%
• Microglial Activation 50%
• Serotoninergic Agents 50%
• All-phase 50%
• TNF Receptor 1 (TNFR1) 50%
• TNF Gene 50%
• Psycho 50%
• Chronic Disorders 50%
• M1 Macrophages 50%
• Neuroimmunomodulation 50%
• Soluble Receptor 50%
• Medication Effects 50%
• PPAR Gene 50%
• Immunomodulatory Action 50%
• Neuroimmunology 50%

Neuroscience

• Neurokinin 100%
• Substance P 100%
• Mood Disorder 100%
• Vortioxetine 100%
• Antidepressant 50%
• Major Depressive Disorder 50%
• Gene Expression 50%
• Interleukin 6 50%
• Proinflammatory Cytokine 50%
• Bipolar Disorder 50%
• Tumor Necrosis Factor Alpha 50%
• Macrophage 50%
• Psychoactive Drug 50%
• Anti-Inflammatory 50%
• Cytokine Production 50%
• Interleukin 4 50%
• Peroxisome Proliferator-Activated Receptor 50%
• Interleukin 50%
• C-Reactive Protein 50%
• Receptor 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Tumor Necrosis Factor 100%
• Pathophysiology 100%
• Mood Disorder 100%
• Disease 80%
• Cytokine 80%
• Substance P 40%
• Neurokinin 40%
• Vortioxetine 40%
• Receptor 20%
• Antidepressant 20%
• C Reactive Protein 20%
• Peroxisome Proliferator Activated Receptor 20%
• Inflammation 20%
• Interleukin 6 20%
• Bipolar Disorder 20%
• Psychotropic Agent 20%
• Antiinflammatory Activity 20%
• Immunomodulation 20%
• Interleukin 4 20%
• Major Depression 20%